Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210367650> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4210367650 endingPage "86" @default.
- W4210367650 startingPage "80" @default.
- W4210367650 abstract "In the modern world there is a growing need for innovative medicines, vaccines, biologicals, diagnostics and gene therapy, especially now that people are aging and more and more microorganisms are becoming resistant to traditional medicines. That is why, the national innovation system of the pharmaceutical market is defined, first of all, as an achievement in biotechnology. And it is no accident that the chemical paradigm for creating drugs is gradually being replaced by a biotechnological paradigm. For example, effective medicines are available today that help defeat diseases that were considered incurable 10-20 years ago. However, despite the fact that science is rapidly progressing today and scientific discoveries are running far ahead, the pace of development and promotion of new drugs for patients who need them remains quite slow. In the world there are a huge number of diseases and conditions for which an effective treatment has not yet been developed. The emergence of new, more effective therapies and drugs is vital. That is, in the modern world there is an increasing interest in the possibilities of developing significant new treatment methods. And most countries support health research and development, and as a result, several important discoveries have taken place in basic biomedical research. In addition, the promotion of an innovation system requires the use of a legislative methodology that allows us to compare the domestic innovation system with the innovation systems of developed countries. In this case, it is necessary to take into account the specifics of the pharmaceutical market. So, each innovative drug has its own life cycle, which on average can last 10 - 15 years and, in addition to time, requires significant financial costs. Billions of dollars are invested in research and development of one drug, and the lion's share of them falls precisely on providing evidence of the quality, safety and effectiveness of the drug through clinical trials." @default.
- W4210367650 created "2022-02-08" @default.
- W4210367650 creator A5058974096 @default.
- W4210367650 creator A9999999999 @default.
- W4210367650 date "2019-01-01" @default.
- W4210367650 modified "2023-09-27" @default.
- W4210367650 title "LEGAL CHARACTERISTICS OF THE NATIONAL INNOVATION SYSTEM IN THE PHARMACEUTICAL MARKET" @default.
- W4210367650 doi "https://doi.org/10.32366/2523-4269-2019-68-3-80-86" @default.
- W4210367650 hasPublicationYear "2019" @default.
- W4210367650 type Work @default.
- W4210367650 citedByCount "1" @default.
- W4210367650 countsByYear W42103676502021 @default.
- W4210367650 crossrefType "journal-article" @default.
- W4210367650 hasAuthorship W4210367650A5058974096 @default.
- W4210367650 hasAuthorship W4210367650A9999999999 @default.
- W4210367650 hasBestOaLocation W42103676501 @default.
- W4210367650 hasConcept C13280743 @default.
- W4210367650 hasConcept C144133560 @default.
- W4210367650 hasConcept C17744445 @default.
- W4210367650 hasConcept C199539241 @default.
- W4210367650 hasConcept C205649164 @default.
- W4210367650 hasConcept C2777526511 @default.
- W4210367650 hasConcept C2779652045 @default.
- W4210367650 hasConcept C71924100 @default.
- W4210367650 hasConcept C83009810 @default.
- W4210367650 hasConcept C94625758 @default.
- W4210367650 hasConcept C98147612 @default.
- W4210367650 hasConcept C98274493 @default.
- W4210367650 hasConceptScore W4210367650C13280743 @default.
- W4210367650 hasConceptScore W4210367650C144133560 @default.
- W4210367650 hasConceptScore W4210367650C17744445 @default.
- W4210367650 hasConceptScore W4210367650C199539241 @default.
- W4210367650 hasConceptScore W4210367650C205649164 @default.
- W4210367650 hasConceptScore W4210367650C2777526511 @default.
- W4210367650 hasConceptScore W4210367650C2779652045 @default.
- W4210367650 hasConceptScore W4210367650C71924100 @default.
- W4210367650 hasConceptScore W4210367650C83009810 @default.
- W4210367650 hasConceptScore W4210367650C94625758 @default.
- W4210367650 hasConceptScore W4210367650C98147612 @default.
- W4210367650 hasConceptScore W4210367650C98274493 @default.
- W4210367650 hasIssue "3" @default.
- W4210367650 hasLocation W42103676501 @default.
- W4210367650 hasOpenAccess W4210367650 @default.
- W4210367650 hasPrimaryLocation W42103676501 @default.
- W4210367650 hasRelatedWork W1970450564 @default.
- W4210367650 hasRelatedWork W2080979683 @default.
- W4210367650 hasRelatedWork W2187797343 @default.
- W4210367650 hasRelatedWork W2351279558 @default.
- W4210367650 hasRelatedWork W2358774705 @default.
- W4210367650 hasRelatedWork W2379299016 @default.
- W4210367650 hasRelatedWork W2940749262 @default.
- W4210367650 hasRelatedWork W3013560731 @default.
- W4210367650 hasRelatedWork W4293462366 @default.
- W4210367650 hasRelatedWork W4323539107 @default.
- W4210367650 hasVolume "68" @default.
- W4210367650 isParatext "false" @default.
- W4210367650 isRetracted "false" @default.
- W4210367650 workType "article" @default.